Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung Cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs) have demonstrated promising outcomes in small cell lung cancer (SCLC), but not all patients benefit from it. Thus, developing precise treatments for SCLC is a particularly urgent need. In our study, we constructed a novel phenotype for SCLC based on im...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yuanfeng, Zheng, Lingnan, Yang, Xi, Luo, Yong, Yi, Cheng, Gou, Hongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Immuno-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628581/
https://www.ncbi.nlm.nih.gov/pubmed/37399175
http://dx.doi.org/10.1093/oncolo/oyad193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628581/
https://www.ncbi.nlm.nih.gov/pubmed/37399175
http://dx.doi.org/10.1093/oncolo/oyad193

Ejemplares similares